AHI Statement Regarding Final Decision By The Commissioner On Fluoroquinolones In Poultry - US - We are disappointed by the decision of the FDA Commissioner to accept the findings of the administrative law judge and order enrofloxacin used to treat sick poultry to be removed from the market.

The loss of this product leaves poultry producers without an important tool to treat sick poultry, and it will reduce animal health and welfare while increasing animal death and suffering.

We continue to believe that decisions about the approval and use of antibiotics to keep animals healthy must be based on sound, data-driven risk assessments.

We will continue to work with the Center for Veterinary Medicine to improve the application of risk assessment to the use of antibiotics in agriculture to ensure the protection of both animal and human health.

Source: Animal Health Institute - 2nd August 2005